The quantal theory of immunity and the interleukin-2-dependent negative feedback regulation of the immune response

Immunological Reviews

Volumn 224, Issue 1, 2008, Pages 124-140

  Smith, Kendall A ^a,b   Popmihajlov, Zoran ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Box 41 ^*  (United States)

Author keywords

FOXP3; Interleukin 2 (IL 2); Negative feedback; Quantal Theory of Immunity; Regulatory T cells

Indexed keywords

AUTOANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR ANTIGEN;

ALLOGRAFT; AUTOIMMUNITY; CELL PROLIFERATION; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR CLONING; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TACHYPHYLAXIS; TRANSCRIPTION REGULATION;

ANIMALS; FEEDBACK, BIOCHEMICAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 49249114167     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00654.x     Document Type: Review

References (107)

1. Burnet FM. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 1957 20 : 67 77.
2. Nowell PC. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res 1960 20 : 462 468.
3. Hirschhorn K, Bach F, Kolodny R, Firschein I, Hashem N. Immune response and mitosis of human peripheral blood lymphocytes in vitro. Science 1963 142 : 1185 1187.
4. Bach F, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964 143 : 813 884.
5. Bain B, Lowenstein L. Genetic studies on the mixed leukocyte reaction. Science 1964 145 : 1315 1316.
6. Cooper M, Peterson R, Good R. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 1965 205 : 143 146.
7. Cooper M, Peterson R, South M, Good R. The functions of the thymus system and the bursa system in the chicken. J Exp Med 1966 123 : 75 102.
8. Raff M. Theta isoantigen as a marker of thymus-derived lymphocytes in mice. Nature 1969 224 : 378 379.
9. Raff M, Sternberg M, Taylor RB. Immunoglobulin determinants on the surface of mouse lymphooid cells. Nature 1970 225 : 553 555.
10. Raff M. Surface antigenic markers for distinguishing T and B lymphocytes. Transplant Rev 1971 6 : 52 59.
11. Andersson J, Moller G, Sjoberg O. Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol 1972 4 : 381 393.
12. Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Schlossman S, Reinherz EL. Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular comlex. J Exp Med 1983 157 : 705 719.
13. Smith KA, Favata MF, Oroszlan S. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol 1983 131 : 1808 1815.
14. Robb RJ, Munck A, Smith KA. T cell growth factor receptors: quantitation, specificity, and biological relevance. J Exp Med 1981 154 : 1455 1474.
15. Meuer SC, et al. Triggering the T3-Ti antigen-receptor complex results in clonal T cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci 1984 81 : 1509 1513.
16. Cantrell DA, Smith KA. Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 1983 158 : 1895 1911.
17. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science 1984 224 : 1312 1316.
18. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988 240 : 1169 1176.
19. Reinherz E, et al. The crystal structure of a T cell recptor in complex with peptide and MHC Class II. Science 1999 286 : 1913 1921.
20. Maynard J, et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 2005 22 : 81 92.
21. Felix N, Allen P. Specificity of T-cell alloreactivity. Nat Rev Immunol 2007 7 : 942 953.
22. Rudolph M, Stanfield R, Wilson I. How TCRS bind MHCS, peptide, and co-receptors. Ann Rev Immunol 2006 24 : 419 466.
23. Huppa J, Gleimer M, Sumen C, Davis M. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat Immunol 2003 4 : 749 755.
24. Krogsgaard M, Li Q-j, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 2005 434 : 238 243.
25. Smith K. The quantal theory of how the immune system discriminates between "self and non-self". Med Immunol 2004 3 : 3.
26. Smith K. The quantal theory of immunity. Cell Res 2006 16 : 11 19.
27. Altan-Bonnet G, Germain RN. Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biology 2005 3 : e356.
28. Podtschaske M, Benary U, Zwinger S, Hofer T, Radbruch A, Baumgrass R. Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression. PLoS ONE 2007 2 : e935.
29. Lohr J, Knoechel B, Abbas A. Regulatory T cells in the periphery. Immunol Rev 2006 212 : 149 162.
30. Choi S, Schwartz R. Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol 2007 19 : 140 152.
31. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998 8 : 591 599.
32. Boyman O, Pyrton J, Sprent J. Cytokines and T cell homeostasis. Curr Opin Immunol 2007 19 : 320 326.
33. Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Ann Rev Immunol 1992 10 : 489 513.
34. Brunet J, et al. A new member of the immunoglobulin superfamily-CTLA-4. Nature 1987 328 : 267 270.
35. Lee KM, et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998 282 : 2263 2266.
36. Alegre M, et al. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 1996 157 : 4762 4770.
37. Liou H, Jin Z, Tumang J, Andjelic S, Smith K, Liou M. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol 1999 11 : 361 371.
38. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992 11 : 3887 3895.
39. Watanabe N, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 2003 4 : 670 679.
40. Ha S-J, West E, Araki K, Smith K, Ahmed R. Manipulating both inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol Rev 2008 223 : 317 333.
41. Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978 120 : 2027 2032.
42. Smith KA. T-cell growth factor. Immunol Rev 1980 51 : 337 357.
43. Smith KA. The interleukin 2 receptor. Annu Rev Cell Biol 1989 5 : 397 425.
44. Smith K. The interleukin-2 receptor. Advan Immuol 1988 42 : 165 179.
45. Gesbert F, Sauvonnet N, Dautry-Varsat A. Clathrin-independent endocytosis and signaling of interleukin-2 receptors (IL-2R) endocytosis and signaling. Curr Top Microbiol Immunol 2004 286 : 119 148.
46. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991 352 : 621 624.
47. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science 1993 262 : 1059 1061.
48. Cousens LP, Orange JS, Biron CA. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol 1995 155 : 5690 5699.
49. Sadlack B, et al. Generalized autoimmune disease in interleukin-2- deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995 25 : 3053 3059.
50. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993 75 : 253 261.
51. Horak I, Lohler J, Ma A, Smith K. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 1995 148 : 35 44.
52. Klebb G, et al. Interleukin-2 Is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 1996 81 : 282 286.
53. Russell W, Russell L, Gower J. Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X/O sex-chromosome constitution is female. Proc Natl Acad Sci USA 1959 45 : 554 560.
54. Godfrey V, Wilkinson J, Rinchik E, Russell L. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA 1991 88 : 5528 5532.
55. Godfrey V, Wilkinson J, Russell L. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991 138 : 1379 1387.
56. Godfrey V, Rouse B, Wilkinson J. Transplantation of a T cell-mediated lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol 1994 145 : 281 286.
57. Blair P, Bultman S, Haas J, Rouse B, Wilkinson J, Godfrey V. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994 153 : 3764 3774.
58. Kanangat S, et al. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. E J Immunol 1996 26 : 161 165.
59. Clark L, Appleby M, Brunkow M, Wilkinson J, Ziegler S, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999 162 : 2546 2554.
60. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 155 : 1151 1164.
61. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996 184 : 387 396.
62. Suri-Payer E, Kehn P, Cheever A, Shevach E. Pathogenesis of post-thymectomy autoimmune gastritis: identification of anti-H/K adenosine triphosphatase-reactive T cells. J Immunol 1996 157 : 1799 1805.
63. Miller J. Effect of neonatal thymectomy on the immunological responsiveness of the mouse. Proc Roy Soc London B 1962 156 : 415 428.
64. Suri-Payer E, Amar A, Thornton A, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory T cells. J Immunol 1998 160 : 1212 1218.
65. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188 : 287 296.
66. Brunkow M, et al. Disruption of a new forkhead/winked-helix protein, scurfin, results in the fatal lymphoprolierative disorder of the scurfy mouse. Nat Genet 2001 27 : 68 73.
67. Schubert L, Jeffrey E, Zhang Y, Ranmsdell F, Ziegler S. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001 276 : 37672 37679.
68. Chatlia T, et al. JM2, encoding a forkhead-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2001 106 : R75 R81.
69. Bennet C, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001 27 : 20 21.
70. Wildin R, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001 27 : 18 20.
71. Fontenot J, Gavin M, Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003 4 : 330 336.
72. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003 299 : 1057 1061.
73. Khattri R, Cox T, Yasayko S-A, Ramsdell F. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003 4 : 337 342.
74. Walker M, et al. Induction of Foxp3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003 112 : 1437 1443.
75. Morgan M, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005 66 : 13 20.
76. Wang J, Ioan-Facsinay A, van der Voort E, Huizinga T, Toes R. Transient expression of FOXP3 in human activated nonregulatory T cells. Eur J Immunol 2007 37 : 129 138.
77. Gavin M, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci 2006 103 : 6659 6664.
78. Ahmadzadeh M, Antony P, Rosenberg S. IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells. J Immunother 2007 30 : 294 302.
79. Allan S, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007 19 : 345 354.
80. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-{beta} dependent but does not confer a regulatory phenotype. Blood 2007 110 : 2983 2990.
81. Villarino A, et al. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med 2007 204 : 65 71.
82. Davidson T, Dipaolo R, Anderson J, Shevach E. IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 2007 178 : 4022 4026.
83. Bopp T, et al. Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression. J Exp Med 2007 204 : 1303 1310.
84. Deaglio S, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007 204 : 1257 1265.
85. Pandiyan P, Zheng L, Ishihara S, Reed S, Lenardo M. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007 8 : 1 10.
86. Burchill M, Yang J, Vogtenhuber C, Blazar B, Farrar M. IL-2 receptor beta-dependent STAT5 activation is required for the development of FOXP3+ regulatory T cells. J Immunol 2007 178 : 280 290.
87. Yao Z, et al. Stat5a/b are essential for normal lymphoid development and differentiation. PNAS 2006 103 : 1000 1005.
88. Zorn E, et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006 108 : 1571 1579.
89. Beadling C, et al. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 1994 13 : 5605 5615.
90. Popmihajlov Z, Smith K. Negative feedback regulation of T cells via interleukin-2 and FOXP3 reciprocity. PLoS ONE 2008 3 : e1581.
91. Garrity PA, Chen D, Rothenberg EV, Wold BJ. Interleukin 2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Bio 1994 14 : 2159 2169.
92. Rothenberg EV, Ward SB. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci USA 1996 93 : 9358 9365.
93. Beadling C, Ng J, Babbage J, Cantrell D. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J 1996 15 : 1902 1913.
94. Yao Z, et al. Nonredundant roles for Stat5a/b in directly regulating FOXP3. Blood 2007 109 : 4368 4375.
95. Mantel P-Y, et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006 176 : 3593 3602.
96. Kim H-P, Leonard W. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007 204 : 1543 1551.
97. Khattri R, et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 2001 167 : 6312 6320.
98. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kB to repress cytokine gene expression and effector functions of T cells. Proc Natl Acad Sci USA 2005 102 : 5138 5143.
99. Grant C, et al. Foxp3 represses retroviral transcription by targeting both NF-kB and CREB pathways. PLoS Pathogens 2006 2 : 303 314.
100. Wu Y, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006 126 : 375 387.
101. Zheng Y, Josefowicz S, Kas A, Chu T-T, Gavin M, Rudensky A. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007 445 : 936 940.
102. Marson A, et al. Foxp3 occupnacy and regulation of key target genes during T-cell stimulation. Nature 2007 445 : 931 935.
103. D'Cruz L, Klein L. Development and function of agonist-induced CD25+Foxp3+regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005 6 : 1152 1159.
104. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin 2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995 4 : 521 530.
105. Suzuki H, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995 268 : 1472 1476.
106. Yamanouchi J, et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Gen 2007 39 : 329 337.
107. Chiodetti L, Barber D, Schwartz R. Biallelic expression of the IL-2 locus under optimal stimulation conditions. Eur J Immunol 2000 30 : 2157 2163.